ASA is also asking for an exemption in implementing drug-to-drug and drug-to-allergy interaction checks. These requested exemptions are aimed to help anesthesiologists reasonably achieve meaningful use and share meaningful data, according to the report.
ASA also teamed with a coalition of physicians specialties to raise concerns about the newest phase of meaningful use criteria, stating that many EHR systems do not work in a way that meets meaningful use requirements or patient needs.
More Articles on Anesthesia:
NAPA: Use STOP-BANG Questionnaire for Sleep Apnea Screening
Lippincott Williams & Wilkins Releases Mobile, Interactive Anesthesia E-Textbook
ASA President Dr. John Zerwas Discusses Anesthesia Awareness in Letter to the Editor
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
